CAS 478336-92-4
:5-Isoxazoleacetic acid, 4,5-dihydro-3-(4-hydroxyphenyl)-, methyl ester
Description:
5-Isoxazoleacetic acid, 4,5-dihydro-3-(4-hydroxyphenyl)-, methyl ester, identified by CAS number 478336-92-4, is a chemical compound characterized by its isoxazole ring structure, which contributes to its unique reactivity and biological properties. This compound features a methyl ester functional group, enhancing its solubility and potential bioavailability. The presence of a 4-hydroxyphenyl group suggests that it may exhibit phenolic characteristics, possibly influencing its antioxidant activity and interactions with biological systems. The dihydro configuration indicates that the compound has a saturated portion, which may affect its stability and reactivity compared to fully unsaturated analogs. Overall, this compound may be of interest in medicinal chemistry and pharmacology, particularly for its potential therapeutic applications, although specific biological activities and mechanisms would require further investigation. As with many chemical substances, safety data and handling precautions should be considered when working with this compound in laboratory settings.
Formula:C12H13NO4
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Methyl 2-(3-(4-Hydroxyphenyl)-4,5-Dihydroisoxazol-5-Yl)Acetate
CAS:Methyl 2-(3-(4-Hydroxyphenyl)-4,5-Dihydroisoxazol-5-Yl)AcetatePurity:99%Molecular weight:235.24g/molISO-1
CAS:Formula:C12H13NO4Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:235.24ISO-1
CAS:<p>ISO-1 (MIF Antagonist) is an inhibitor of the dopachrome tautomerase activity, blocks the activation of NF-κB/TNF-α secretion from LPS-treated macrophages.</p>Formula:C12H13NO4Purity:98.06% - 98.65%Color and Shape:SolidMolecular weight:235.24Methyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
CAS:Formula:C12H13NO4Purity:98%Molecular weight:235.239MIF Antagonist, ISO-1
CAS:<p>ISO-1 is a novel MIF antagonist that has been shown to inhibit the activation of WST-1. ISO-1 is currently being studied for its effects on autoimmune diseases, cancer and bowel disease. ISO-1 blocks the chemoattractant protein CXCL12, which is used to recruit white blood cells to the site of inflammation. It also inhibits enzymes that are involved in oxidative stress and inflammation, such as LOX and COX2. ISO-1 has been shown to inhibit the production of growth factor β1, which is responsible for stimulating cell proliferation. This drug has been tested in an experimental model for epithelial mesenchymal transition (EMT) and found to have therapeutic potential in bowel disease.</p>Formula:C12H13NO4Purity:Min. 95%Molecular weight:235.24 g/mol





